Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies

Author： Labruijere Sieneke   Ibrahimi Khatera   Chan Kayi Y   MaassenVanDenBrink Antoinette  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.8, Iss.11, 2013-11, pp. : 1309-1323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calcitonin gene-related peptide receptor antagonists for migraine

By Fischer Michael JM  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 7, 2010-07 ,pp. : 815-823

Informa Healthcare

Access to resources Recommend Favorite

Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists in the Treatment of Migraine

By Durham Paul L.   Vause Carrie V.  

CNS Drugs, Vol. 24, Iss. 7, 2010-07 ,pp. : 539-548

Adis International

Access to resources Recommend Favorite

Modelling the Anti-Migraine Effects of BIBN 4096 BS: A New Calcitonin Gene-Related Peptide Receptor Antagonist

By Trocóniz Iñaki F.  

Clinical Pharmacokinetics, Vol. 45, Iss. 7, 2006-01 ,pp. : 715-728

Adis International

Access to resources Recommend Favorite

Calcitonin Gene-Related Peptide Antagonists as Treatments of Migraine and Other Primary Headaches

By Goadsby Peter J.  

Drugs, Vol. 65, Iss. 18, 2005-01 ,pp. : 2557-2567

Adis International

Access to resources Recommend Favorite

Receptor subtypes mediating renal actions of calcitonin gene-related peptide

By Elhawary A.M.   Poon J.S.   Pang C.C.Y.  

European Journal of Pharmacology, Vol. 286, Iss. 3, 1995-11 ,pp. : 255-263

Elsevier

Access to resources Recommend Favorite